Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
post
Regulatory Medical Writing: What Is It and What Do They Do?
Read More
post
CMC Safety and Efficacy in Gene and Cell Therapies
Read More
post
Accelerating Drug Development: Regulatory Strategies for Fast-Track and Breakthrough Therapy Designations
Read More
post
Navigating the Evolution from ICH Q2(R1) to ICH Q2(R2) and Implementation of ICH Q14 in Biopharmaceutical Method Validation
Read More
Let's move from science to success.
Let’s Talk